Naomi Fersht Selected Research

Carcinoma (Carcinomatosis)

12/2014

Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naomi Fersht Research Topics

Disease

4	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 04/2016
2	Combined Pituitary Hormone Deficiency 10/2023 - 01/2021
2	Meningioma (Meningiomas) 01/2019 - 03/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 12/2017 - 12/2014
1	Neoplasms (Cancer) 04/2024
1	Astrocytoma (Pilocytic Astrocytoma) 04/2024
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2023
1	Hypopituitarism (Sheehan's Syndrome) 10/2023
1	Hypothyroidism 10/2023
1	Glioma (Gliomas) 01/2021
1	Paraganglioma (Paragangliomas) 12/2017
1	Neoplasm Metastasis (Metastasis) 04/2016
1	Primitive Neuroectodermal Tumors (PNET) 04/2016
1	Carcinoma (Carcinomatosis) 12/2014
1	Adenoma (Adenomas) 12/2014
1	Vision Disorders (Hemeralopia) 03/2013
1	Craniopharyngioma (Craniopharyngiomas) 03/2013

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 01/2021
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2023 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 04/2016
1	Hormones (Hormone)IBA 10/2023
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2017
1	Peptide Receptors (Peptide Receptor)IBA 12/2014
1	Radioisotopes (Radionuclides)IBA 12/2014
1	LutetiumIBA 12/2014

Therapy/Procedure

6	Radiotherapy 10/2023 - 03/2013
2	Therapeutics 10/2023 - 12/2014
1	Adjuvant Radiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 12/2017
1	Craniospinal Irradiation 04/2016